Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Added:
3 days ago
Video Series
Added:
9 months ago
Discover the essential elements of effective multidisciplinary heart team collaboration in transcatheter and surgical aortic valve replacement with Dr Carla Agiatiello (Hospital Italiano, Buenos Aires, Argentina).This presentation, part of the Structural Interventions track, explores the critical role of comprehensive team-based decision-making in optimizing patient outcomes for aortic valve…
View more
Added:
1 year ago
Join this insightful discussion on women's cardiovascular health!ICR3 Guest Editor, Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), leads a conversation with Drs Julia Grapsa (Guy's and St Thomas' NHS Foundation Trust, UK) and Ahmed Krimly (King Faisal Cardiac Center, SA), authors of a special focus issue on this critical topic.Key themes explored:Disparities in heart failure care for…
View more
Added:
4 days ago
In this episode of Masterclass, host, Dr Harriette Van Spall speaks with Professor Faiez Zannad about the challenge of making heart failure evidence more globally representative.Professor Zannad is an emeritus Professor of Therapeutics and Cardiology at the University of Lorraine in Nancy, France, and a leading clinical trialist in heart failure whose studies have informed international treatment…
View more
Added:
1 month ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes…
View more
Added:
6 months ago
Added:
3 months ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more
Added:
1 year ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more
Targeting Obesity for Heart Failure
Added:
4 months ago
Review Article
Added:
6 months ago
AHA Scientific Sessions 2025 - Dr Clyde Yancy (Northwestern University, US) joins us to explore the future trajectory of heart failure management, examining how prevention strategies, precision medicine approaches, and the evolving responsibilities of cardiologists are reshaping patient outcomes.Interview Questions:Looking at the current state of heart failure management, what do you see as the…
View more